MedTrace Logo

1C70 Feasibility Study

NCT05628064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-06-10

No results posted yet for this study

Summary

The objective of this study is to characterize the extent of 1C70 meeting the amputees needs in comparison with their everyday and a comparator foot, in regards of daily activities, mobility and balance, as well as quality of life and pain.

Conditions

  • Amputation

Interventions

DEVICE

1C70

Investigational energy storage and return prosthetic foot with using novel elastic elements.

DEVICE

Pro-Flex XC

Commercially available carbon-fiber energy storage and return foot used as comparative foot for transtibial amputee subjects.

Sponsors & Collaborators

  • Ottobock SE & Co. KGaA

    collaborator UNKNOWN

  • Otto Bock Healthcare Products GmbH

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-24
Primary Completion
2023-05-30
Completion
2023-06-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05628064 on ClinicalTrials.gov